Authors : Shivendra Mishra; Devashish Jena; Vikash Kumar Patel; Sandip Kumar

Volume/Issue : Volume 10 - 2025, Issue 4 - April

Google Scholar : https://tinyurl.com/357ax299

Scribd : https://tinyurl.com/yvfd2evr

DOI : https://doi.org/10.38124/ijisrt/25apr1309

Google Scholar

Note : A published paper may take 4-5 working days from the publication date to appear in PlumX Metrics, Semantic Scholar, and ResearchGate.

Note : Google Scholar may take 15 to 20 days to display the article.

Abstract : Pharmaceutical marketing is an activity which narrates the means and ways utilized by the drug companies in promoting their medication among medical practitioners, patients, and other customers. Pharmaceutical marketing encompasses a vast ground which comprises many activities such as direct-to-consumer marketing, doctor detailing, sampling of the drugs, electronic marketing, and market access models. Although the objective of pharmaceutical promotion is to grow the sale of medicines, it has the purpose of educating drug providers and patients in regard to therapy modalities too. Pharmaceutical marketing, however, is normally covered in moral dilemmas, particularly the effect that it places on drug costs and prescribing. The abstract below explores the fundamental aspects of pharmaceutical marketing, upcoming digital trends, regulatory concerns involved, and ethical considerations related to its practices. A balance and transparency that is effective is needed in order to ensure that marketing activities advance public health goals and offer trust to all concerned take holders.

Keywords : Introduction, Important Element, Classification, Drug Profile, Market Survey.

References :

1. 1. Mandel, H., & Shalata, A. (2005).Methylcobalamin and its role in cellular functions and health. Journal of Nutrition, 135(6), 1329-1334.
   2. Vannucchi, M. G., et al. (2002).Methylcobalamin supplementation in patients with vitamin B12 deficiency-related neuropathy. European Journal of Neurology, 9(4), 383-386.
   3. Schaefer, E. J., & Lichtenstein, A. H. (2007).Vitamin B12 (Cobalamin) Deficiency and Methylcobalamin: Biochemistry and Clinical Implications. Journal of Clinical Pharmacology, 47(4), 470-476.
   4. Watanabe, F., et al. (2007).Bioavailability of methylcobalamin in humans: a review. Journal of Nutritional Biochemistry, 18(12), 763-767.
   5. Vannucchi, M. G., et al. (2002).Methylcobalamin supplementation in patients with vitamin B12 deficiency-related neuropathy. European Journal of Neurology, 9(4), 383-386.
   6. Ribaya-Mercado, J. D., & McNeill, G. (2006).Methylcobalamin as an active form of vitamin B12. Journal of Nutrition, 136(10), 2690-2694.
   7. Sinn, N., & Bryan, J. (2007).Methylcobalamin and its effects on neurological health. Journal of Clinical Neurology, 3(2), 65-70.
   8. Hansen, R. S. (2007).Pharmaceutical marketing: A global perspective. International Journal of Pharmaceutical and Healthcare Marketing, 1(3), 203-217.
   9. Stern, S., & Stokes, R. (2008).Pharmaceutical marketing: Ethics and regulation. Pharmaceutical Marketing & Management, 4(2), 45-50.
   10. Figueiredo, C., & Nakano, D. (2010).The role of digital marketing in the pharmaceutical industry: A case study on social media use. Journal of Business Research, 63(4), 387-395.
   11. Harris, J. L., & Schwartz, M. B. (2019).The role of marketing in shaping pharmaceutical product use: The case of off-label marketing. American Journal of Public Health, 109(1), 25-30.